Noticias de FXI_US
Noticias del mercado
Últimas noticias sobre FXI_US — 7236 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
How China is conquering high-tech markets once controlled by the West
Not Long Ago, Trump Accused China of Election Meddling. Today, ‘Great Friendship.’
Opinion | Ban Chinese cars? They’re already here.
The case for talking to China is not a case for détente
At State Dinner for China’s Leader, Melania Trump Wears the Pants
US ambassador to China: ‘Best thing’ from Xi visit ‘is to continue the conversation’
The Chinese AI Infrastructure Boom: Introducing the SemiAnalysis China Datacenter Model
Over 3,000 Tibetans, Chinese dissidents, Uyghurs, Hong Kongers, and other groups joined protests during Xi’s state visit, calling for human rights and political freedom.
The Plaza Accord was not an externally imposed punishment of Japan but part of a broader restructuring that Japanese economists and policymakers themselves recognized was necessary. Its effects were undermined, however, when Tokyo responded to the resulting slowdown with policies that exacerbated investment, credit expansion, and the very imbalances the adjustment was intended to resolve.
US being left behind in EV charging speeds as China goes sub-5 min to 70%
How China is rethinking tank survival against FPVs and top-attack threats
Details on US, China trade talks to come on Monday, says Greer
Over 30 CEOs scored an invite to the US-China state dinner — and these 4 got a spot at the head table
Top White House trade official Jamieson Greer said the two days of talks between President Trump and Chinese leader Xi brought some trade matter agreements.
Top White House trade official Jamieson Greer said the two days of talks between President Trump and Chinese leader Xi brought some trade matter agreements.
A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “Ne | A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “NewCo” model.
After Xi-Trump summit, US-China rivalry remains frozen. Is this to Beijing's advantage?
Jannik Sinner withdraws from China Open as knee injury lingers
Página 30 de 100